共 50 条
Triple therapy or etanercept after methotrexate failure in RA?
被引:0
|作者:
Ronald F. van Vollenhoven
Katerina Chatzidionysiou
机构:
[1] Unit for Clinical Therapy Research,
[2] Inflammatory Diseases,undefined
[3] The Karolinska Institute,undefined
[4] Karolinska University Hospital,undefined
[5] D1:00,undefined
来源:
Nature Reviews Rheumatology
|
2013年
/
9卷
关键词:
D O I:
暂无
中图分类号:
学科分类号:
摘要:
Since the 1990s, patients with rheumatoid arthritis have been treated with at least one DMARD. Methotrexate, which is usually the first-line treatment, elicits good or even excellent clinical results in 20–30% of patients—but in most patients it does not. Thus, an important question is what to do after methotrexate failure.
引用
收藏
页码:510 / 512
页数:2
相关论文